Przejdź do zawartości
Merck

MR imaging findings for differentiating cutaneous malignant melanoma from squamous cell carcinoma.

European journal of radiology (2020-09-27)
Masaya Kawaguchi, Hiroki Kato, Hiroyuki Tomita, Akira Hara, Natsuko Suzui, Tatsuhiko Miyazaki, Kanako Matsuyama, Mariko Seishima, Masayuki Matsuo
ABSTRAKT

This study aimed to assess the efficacy of using MR imaging findings for differentiating cutaneous malignant melanoma (cMM) from cutaneous squamous cell carcinoma (cSCC). Preoperative MR images of patients with histopathologically proven primary cMM and primary cSCC were retrospectively reviewed and compared between the two pathologies. A total of 16 patients with primary cMM (7 men and 9 women; age range, 45-97 years; median age, 75 years) and 49 with primary cSCC (37 men and 12 women; age range, 46-90 years; median age, 76 years) were enrolled in this study. Intratumoral T1 hyperintensity compared to that of the dermis was more frequently observed in cMM than in cSCC (50 % vs. 4 %; p < 0.01). Superficial depression (51 % vs. 19 %; p < 0.05), superficial irregular margins (55 % vs. 25 %; p <  0.05), and reticular or linear T2 hyperintensity (27 % vs. 0 %; p <  0.05) were more frequently observed in cSCC than in cMM, respectively. cMM predominantly exhibited intratumoral T1 hyperintensity, whereas cSCC predominantly exhibited superficial depression, superficial irregular margins, reticular or linear T2 hyperintensity.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
3,3′-Diiodo-L-thyronine (T2) hydrochloride, 98% (CP)